Screener
Recursion Pharmaceuticals, Inc. RXRX Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
FAQ
- What is Recursion Pharmaceuticals, Inc.'s price / book?
- Recursion Pharmaceuticals, Inc. (RXRX) reported price / book of 2.1× in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s price / book changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s price / book decreased by 7.8% year-over-year, from 2.3× to 2.1×.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s price / book?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s price / book has grown at a -23.1% compound annual growth rate (CAGR), from 5.4× to 1.9×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Recursion Pharmaceuticals, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude